Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
COMPANY ANNOUNCEMENT NO. 10-2026FLSmidth & Co. A/S11 February 2026Copenhagen, Denmark On 25 June 2025, FLSmidth & Co. A/S (“FLSmidth”) initiated a share buy-back programme of up to DKK 1.4...
-
Silicon Valley Acquisition Corp. Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on February 12, 2026
-
SPRINGDALE, Ark., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Tyson Foods, Inc. (the “Company” or “we”) (NYSE: TSN) announced today that it has agreed to sell $500 million aggregate principal amount of its...
-
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES...
-
NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced that it has granted to Dr. Minako Pazdera, the new General...
-
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. CALGARY, Alberta, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Zedcor Inc. (the "Company" or “Zedcor”) (TSX...
-
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug...
-
BOSTON, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a biopharmaceutical company focused on developing novel therapeutics to redefine the treatment paradigm for people living with...
-
TORONTO, 10 févr. 2026 (GLOBE NEWSWIRE) -- Ninepoint 2024 Short Duration Flow-Through Limited Partnership II (la « société en commandite ») a annoncé aujourd’hui qu’elle avait terminé le...
-
TORONTO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Ninepoint 2024 Short Duration Flow-Through Limited Partnership II (the “Partnership”), announced today that it had completed the tax-deferred transfer of...